The combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: Comparison with prednisolone therapy

Japanese Journal of Nephrology

Volumn 50, Issue 5, 2008, Pages 581-587

  Hayashi, Masanori ^a   Kimura, Noriyo ^c   Fukatsu, Atsushi ^b  

^a FUKUI PREFECTURAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c NONE

Author keywords

Cyclosporin; Minimal change nephrotic syndrome; Prednisolone

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; HUMAN; INFECTION; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; MONOTHERAPY; OSTEOPOROSIS; PROTEINURIA; RECURRENT DISEASE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENGTH OF STAY; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; PREDNISOLONE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 51149095245     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Nephron 1999 ; 82 : 205-213.
2. Bargman JM. Management of minimal lesion glomerulonephritis ; Evidence-based recommendation. Kidney Int 1999 ; 55 (Suppl 70) : S3-S16.
3. Nawata H, Soen S, Takayanagi R, et al. Guidelines on the management and treatment of glucocorticoid induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005 ; 23 : 105-109.
4. Japanese source
5. Japanese source
6. Chishti AS, Sorof JM, Brewer ED, Kale AS. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 2001 ; 38 : 754-760.
7. Japanese source
8. Japanese source
9. Japanese source
10. Japanese source
11. Mihatsch MJ, Antonovych T, Bohman SO, et al. Cyclosporin A nephropathy : standardization of the evaluation of kidney biopsies. Clin Nephrol 1994 ; 41 : 23-32.
12. Ishikawa A, Fujita K, Suzuki K. The influence of temocapril, an angiotensin converting enzyme inhibitor, on the cyclosporine-induced nephrotoxicity. J Urol 1997 ; 157 : 739-742.
13. Burdmann EA, Andoh TF, Nast CC, et al. Prevention of experimental cyclosporine-induced interstitial fibrosis by losartan and enalapril, Am J Physiol 1995 ; 269 : F491-F499.
14. 1 and matrix proteins in cyclosporin nephropathy. Kidney Int 1997 ; 52 : 660-673.